These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18038451)

  • 1. Peroxisome proliferator-activated receptor-beta/delta protects against chemically induced liver toxicity in mice.
    Shan W; Nicol CJ; Ito S; Bility MT; Kennett MJ; Ward JM; Gonzalez FJ; Peters JM
    Hepatology; 2008 Jan; 47(1):225-35. PubMed ID: 18038451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression.
    Shan W; Palkar PS; Murray IA; McDevitt EI; Kennett MJ; Kang BH; Isom HC; Perdew GH; Gonzalez FJ; Peters JM
    Toxicol Sci; 2008 Oct; 105(2):418-28. PubMed ID: 18622026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau hyperphosphorylation and increased BACE1 and RAGE levels in the cortex of PPARβ/δ-null mice.
    Barroso E; del Valle J; Porquet D; Vieira Santos AM; Salvadó L; Rodríguez-Rodríguez R; Gutiérrez P; Anglada-Huguet M; Alberch J; Camins A; Palomer X; Pallàs M; Michalik L; Wahli W; Vázquez-Carrera M
    Biochim Biophys Acta; 2013 Aug; 1832(8):1241-8. PubMed ID: 23507144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase-2 enhances inhibition of skin tumorigenesis.
    Bility MT; Zhu B; Kang BH; Gonzalez FJ; Peters JM
    Toxicol Sci; 2010 Jan; 113(1):27-36. PubMed ID: 19748995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of chemically induced skin carcinogenesis by sulindac is independent of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta).
    Kim DJ; Prabhu KS; Gonzalez FJ; Peters JM
    Carcinogenesis; 2006 May; 27(5):1105-12. PubMed ID: 16418176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial, but not smooth muscle, peroxisome proliferator-activated receptor β/δ regulates vascular permeability and anaphylaxis.
    Wawrzyniak M; Pich C; Gross B; Schütz F; Fleury S; Quemener S; Sgandurra M; Bouchaert E; Moret C; Mury L; Rommens C; Mottaz H; Dombrowicz D; Michalik L
    J Allergy Clin Immunol; 2015 Jun; 135(6):1625-35.e5. PubMed ID: 25556996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of PPARβ/δ adversely affects satellite cells and reduces postnatal myogenesis.
    Chandrashekar P; Manickam R; Ge X; Bonala S; McFarlane C; Sharma M; Wahli W; Kambadur R
    Am J Physiol Endocrinol Metab; 2015 Jul; 309(2):E122-31. PubMed ID: 25921579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist-induced activation releases peroxisome proliferator-activated receptor beta/delta from its inhibition by palmitate-induced nuclear factor-kappaB in skeletal muscle cells.
    Jové M; Laguna JC; Vázquez-Carrera M
    Biochim Biophys Acta; 2005 May; 1734(1):52-61. PubMed ID: 15866483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of aryl hydrocarbon receptor (AHR)-dependent signaling by peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in keratinocytes.
    Borland MG; Krishnan P; Lee C; Albrecht PP; Shan W; Bility MT; Marcus CB; Lin JM; Amin S; Gonzalez FJ; Perdew GH; Peters JM
    Carcinogenesis; 2014 Jul; 35(7):1602-12. PubMed ID: 24639079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of Cytochrome P450 2B10 (CYP2B10) Expression in Liver by Peroxisome Proliferator-activated Receptor-β/δ Modulation of SP1 Promoter Occupancy.
    Koga T; Yao PL; Goudarzi M; Murray IA; Balandaram G; Gonzalez FJ; Perdew GH; Fornace AJ; Peters JM
    J Biol Chem; 2016 Nov; 291(48):25255-25263. PubMed ID: 27765815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPARβ/δ modulates ethanol-induced hepatic effects by decreasing pyridoxal kinase activity.
    Goudarzi M; Koga T; Khozoie C; Mak TD; Kang BH; Fornace AJ; Peters JM
    Toxicology; 2013 Sep; 311(3):87-98. PubMed ID: 23851158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand activation of peroxisome proliferator-activated receptor beta inhibits colon carcinogenesis.
    Marin HE; Peraza MA; Billin AN; Willson TM; Ward JM; Kennett MJ; Gonzalez FJ; Peters JM
    Cancer Res; 2006 Apr; 66(8):4394-401. PubMed ID: 16618765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes.
    Planavila A; Rodríguez-Calvo R; Jové M; Michalik L; Wahli W; Laguna JC; Vázquez-Carrera M
    Cardiovasc Res; 2005 Mar; 65(4):832-41. PubMed ID: 15721863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of cardiac Angptl4 by dietary fatty acids is mediated by peroxisome proliferator-activated receptor beta/delta and protects against fatty acid-induced oxidative stress.
    Georgiadi A; Lichtenstein L; Degenhardt T; Boekschoten MV; van Bilsen M; Desvergne B; Müller M; Kersten S
    Circ Res; 2010 Jun; 106(11):1712-21. PubMed ID: 20378851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand activation of peroxisome proliferator-activated receptor-β/δ suppresses liver tumorigenesis in hepatitis B transgenic mice.
    Balandaram G; Kramer LR; Kang BH; Murray IA; Perdew GH; Gonzalez FJ; Peters JM
    Toxicology; 2016 Jul; 363-364():1-9. PubMed ID: 27427494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease.
    Zarei M; Barroso E; Palomer X; Dai J; Rada P; Quesada-López T; Escolà-Gil JC; Cedó L; Zali MR; Molaei M; Dabiri R; Vázquez S; Pujol E; Valverde ÁM; Villarroya F; Liu Y; Wahli W; Vázquez-Carrera M
    Mol Metab; 2018 Feb; 8():117-131. PubMed ID: 29289645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPARbeta/delta potentiates PPARgamma-stimulated adipocyte differentiation.
    Matsusue K; Peters JM; Gonzalez FJ
    FASEB J; 2004 Sep; 18(12):1477-9. PubMed ID: 15247146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta) inhibits chemically induced skin tumorigenesis.
    Bility MT; Devlin-Durante MK; Blazanin N; Glick AB; Ward JM; Kang BH; Kennett MJ; Gonzalez FJ; Peters JM
    Carcinogenesis; 2008 Dec; 29(12):2406-14. PubMed ID: 18799709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The peroxisome proliferator-activated receptor β/δ (PPARβ/δ) agonist GW501516 prevents TNF-α-induced NF-κB activation in human HaCaT cells by reducing p65 acetylation through AMPK and SIRT1.
    Barroso E; Eyre E; Palomer X; Vázquez-Carrera M
    Biochem Pharmacol; 2011 Feb; 81(4):534-43. PubMed ID: 21146504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional profiling reveals divergent roles of PPARalpha and PPARbeta/delta in regulation of gene expression in mouse liver.
    Sanderson LM; Boekschoten MV; Desvergne B; Müller M; Kersten S
    Physiol Genomics; 2010 Mar; 41(1):42-52. PubMed ID: 20009009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.